Laboratory practices and incidence of non-O157 shiga toxin-producing Escherichia coli infections
- PMID: 22377034
- PMCID: PMC3309587
- DOI: 10.3201/eid1803.111358
Laboratory practices and incidence of non-O157 shiga toxin-producing Escherichia coli infections
Abstract
We surveyed laboratories in Washington State, USA, and found that increased use of Shiga toxin assays correlated with increased reported incidence of non-O157 Shiga toxin-producing Escherichia coli (STEC) infections during 2005-2010. Despite increased assay use, only half of processed stool specimens underwent Shiga toxin testing during 2010, suggesting substantial underdetection of non-O157 STEC infections.
Figures
Comment in
-
Nonculture diagnostic tests for enteric diseases.Emerg Infect Dis. 2012 Mar;18(3):513-4. doi: 10.3201/eid1803.111914. Emerg Infect Dis. 2012. PMID: 22377326 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Recommendations for diagnosis of Shiga toxin–producing Escherichia coli infections by clinical laboratories. MMWR Morb Mortal Wkly Rep. 2009;58:1–14. - PubMed
-
- Moody R, Tarr PI. Shiga toxin–producing Escherichia coli infections: what clinicians need to know. Clinician outreach and communication activity conference call. 2010. Sept 16 [cited 2011 Aug 11]. http://www.bt.cdc.gov/coca/ppt/09_16_10_ShigaEColi_FINAL.pdf
-
- Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365:1073–86. - PubMed
-
- Centers for Disease Control and Prevention. Importance of culture confirmation of Shiga toxin–producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis—New York and North Carolina, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:1042–5. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical